Sales rise 12.04% to Rs 222.70 crore
Net profit of Orchid Pharma rose 37.58% to Rs 27.24 crore in the quarter ended September 2024 as against Rs 19.80 crore during the previous quarter ended September 2023. Sales rose 12.04% to Rs 222.70 crore in the quarter ended September 2024 as against Rs 198.76 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales222.70198.76 12 OPM %13.6211.73 -PBDT34.5327.86 24 PBT25.9020.02 29 NP27.2419.80 38Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Supreme Court, SC")
 "Equity markets around the world continue to be on a tear. The MSCI Global Equity Index is close to its lifetime highs, up a staggering 30 per cent over the last year. But it is not just equities; all asset classes have thrived in recent months.")
 "Women's Asian Champions Trophy 2024")
 "Flipkart wishmasters delivering orders on EVs")
 "Will Lansing, chief executive officer (CEO) of FICO")
